| FSSA ASIAN EQUITY PLUS VI EUR CAP | RVI ASIA EX-JAPÓN VALOR | 33,68% | 36,24% | 28,61% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 58,08% | 69,21% | 28,60% | · |
| AMUNDI FUNDS JAPAN EQUITY SELECT R EUR (C) | RVI JAPÓN | 30,56% | 40,98% | 28,59% | · |
| CAPITAL GROUP EMERGING MARKETS EQUITY FUND (LUX) ZL USD | RVI EMERGENTES | 40,20% | 53,48% | 28,59% | · |
| FIDELITY FUNDS-ASIAN SMALLER COMPANIES A-ACC-USD | RVI ASIA EX-JAPÓN SMALL/MID CAP | 8,81% | 19,80% | 28,58% | 93,36% |
| GOLDMAN SACHS SHORT DURATION OPPORTUNISTIC CORPORATE BOND PORTFOLIO I EUR CAP | DEUDA PRIVADA GLOBAL CORTO PLAZO | 6,18% | 18,71% | 28,58% | · |
| GLOBAL OPPORTUNITIES ACCESS - EQUITIES EURH F-ACC | RVI GLOBAL | 18,93% | 38,22% | 28,57% | · |
| NORDEA 1-EMERGING SUSTAINABLE STARS EQUITY FUND BC-USD | RVI EMERGENTES | 58,85% | 73,37% | 28,57% | 178,14% |
| SCHRODER ISF EMERGING MARKET BOND I ACC USD | RFI EMERGENTES | 13,67% | 31,00% | 28,57% | 52,22% |
| UBAM - EMERGING MARKETS FRONTIER BOND IEHC EUR | RFI EMERGENTES HRD CCY | 18,01% | 64,90% | 28,57% | · |
